LGMN and Parkinson disease: To interrogate the pathological roles of Sox6 and ALDH1A1 cleavage by AEP, we treated 6‐month‐old C57BL/6J mice with low dose of rotenone (1 mg kg−1, i.p.),[25] which was previously shown to exhibit most PD pathologies and motor disorders.